Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
05/2012
05/10/2012WO2012019428A8 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof
05/10/2012WO2011130462A3 Intraocular pressure reduction with intracameral bimatoprost implants
05/10/2012US20120116216 Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection
05/10/2012US20120115959 Therapeutic Compositions And Methods
05/10/2012US20120115957 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
05/10/2012US20120115921 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
05/10/2012US20120115907 Novel compounds as inhibitors of renin
05/10/2012US20120115903 Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115902 3H-Imidazo [4, 5-B] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
05/10/2012US20120115893 Substituted Bicyclic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115890 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
05/10/2012US20120115886 Fused pyrimidineone compounds as trpv3 modulators
05/10/2012US20120115874 Pyrazine derivatives, process for manufacture and use thereof
05/10/2012US20120115870 Control of intraocular pressure using alk5 modulation agents
05/10/2012US20120115869 Tetrazole derivatives
05/10/2012US20120115859 3,4,5-substituted piperidines as renin inhibitors
05/10/2012US20120115854 Pharmaceutical composition containing antihypertensive agents
05/10/2012US20120115829 Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection
05/10/2012US20120115826 Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 AdrenergicReceptor
05/10/2012US20120115815 Compositions useful especially for treatment or prevention of metabolic syndrome
05/10/2012US20120115803 Treatment of acinetobacter with alginate oligomers and antibiotics
05/10/2012US20120115799 Pharmaceutical formulations
05/10/2012US20120115794 Use of cd44v6 in the treatment of ophthalmic diseases
05/10/2012US20120115783 Peptidomimetic macrocycles
05/10/2012US20120115773 Modified omci as a complement inhibitor
05/10/2012US20120115771 Carrier
05/10/2012US20120114768 Angiogenesis regulating composition and method for regulating angiogenesis
05/10/2012US20120114759 Peptide/particle delivery systems
05/10/2012US20120114745 Method for treating or ameliorating mucocutaneous or ocular toxicities
05/10/2012US20120114712 Umbilical cord biomaterial for medical use
05/10/2012US20120114701 Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
05/10/2012US20120114668 Method for modulating angiogenesis using fibromodulin
05/10/2012US20120114637 Mtor pathway inhibitors for treating ocular disorders
05/10/2012US20120114630 Variants of plasminogen and plasmin
05/10/2012US20120114619 Protein with promoting effects for axonal growth of neurons of central nervous system
05/10/2012US20120114577 Peptide Having Activity of Transforming Growth Factor and Production Method Therefor
05/10/2012DE102010050570A1 Zusammensetzung und Arzneimittel enthaltend ω-3-Fettsäuren sowie einen Inhibitor des NF-κB-Transkriptionsfaktors Composition and medicines containing ω-3 fatty acids as well as an inhibitor of NF-kB transcription factor
05/10/2012CA2813671A1 Pharmaceutical combinations for the treatment of metabolic disorders
05/09/2012EP2448587A1 Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
05/09/2012EP2448569A2 Pharmacology of visual cycle modulators
05/09/2012EP2213292B1 Double-stranded oligonucleotides
05/09/2012EP1492536B1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
05/09/2012CN102449140A Methods of inhibiting photoreceptor apoptosis
05/09/2012CN102448941A Substituted isoquinoline derivative
05/09/2012CN102448940A Pharmaceutical composition for treating or preventing glaucoma
05/09/2012CN102443521A Manufacturing method of ginseng wolfberry wine
05/09/2012CN102441158A Eye drop having Cecropins for pet and preparation method thereof
05/09/2012CN102441085A Traditional Chinese medicine for treating iridocyclitis
05/09/2012CN102441072A Health care powder for rehabilitation of presbyopia
05/09/2012CN102441070A Composition for alleviating eye fatigue
05/09/2012CN102441031A Traditional Chinese medicine for treating acute and chronic otitis media
05/09/2012CN102441019A Chinese medicinal chrysanthemum buccal tablet
05/09/2012CN102441001A Compound allantoin vitamin B6-E and ammoniation ethyl sulfate eye drops and preparation method thereof
05/09/2012CN101987084B Chitosan-collagen sustained-release eye drop and preparation method
05/09/2012CN101633644B N3 alkylated benzimidazole derivatives as mek inhibitors
05/09/2012CN101522633B 6-substituted isoquinoline derivatives as ROCK-I inhibitors
05/09/2012CN101511796B Imidazole derivative
05/09/2012CN101503458B Small molecule polypeptide for preventing and treating angiogenesis and use thereof
05/08/2012US8173138 Stable liquid formulations of botulinum toxin
05/08/2012US8173129 Methods and compositions for treating autoimmune diseases
05/08/2012US8173121 Lysyl oxidase-like 1 (LOXL1) and elastogenesis
05/08/2012CA2673751C Protective agent for retinal nerve or optic nerve
05/08/2012CA2478655C Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/08/2012CA2469334C Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
05/08/2012CA2377661C Use of fatty acid derivative for the treatment of external secretion disorders
05/03/2012WO2012058224A1 Ophthalmic compositions
05/03/2012WO2012057262A1 Pyridine derivative and medicinal agent
05/03/2012WO2012056229A1 Inflammatory disease
05/03/2012WO2012055884A1 Dosing regimes for the treatment of ocular vascular disease
05/03/2012WO2012055571A1 Ophthalmic composition
05/03/2012WO2012003145A3 Therapeutic agents for ocular hypertension
05/03/2012US20120108672 Ophthalmic composition and method for prevention of cloudiness/precipitation
05/03/2012US20120108658 Ophthalmic composition
05/03/2012US20120108657 Disease-associated protein
05/03/2012US20120108654 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa
05/03/2012US20120108647 Therapeutic uses of inhibitors of rtp801l
05/03/2012US20120108632 Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
05/03/2012US20120108627 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation
05/03/2012US20120108617 Methods and compositions involving (s)-bucindolol
05/03/2012US20120108614 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108613 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108607 Optically active 3-[(phenylpiperazin-1-yl)alkyl]-3- alkyl-oxindole derivatives having cns activity
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108587 Aza- and Diaza-Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
05/03/2012US20120108583 Tricyclic Compounds As mPGES-1 Inhibitors
05/03/2012US20120108582 Fused substituted aminopyrrolidine derivative
05/03/2012US20120108566 Nicotinamides as jak kinase modulators
05/03/2012US20120108557 Fluoroquinolone derivatives for ophthalmic applications
05/03/2012US20120108551 Ophthalmic compositions
05/03/2012US20120108534 Dihydrothienopyrimidines for the treatment of inflammatory Diseases
05/03/2012US20120108523 Disease-associated protein
05/03/2012US20120108505 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
05/03/2012US20120107897 Double-stranded oligonucleotides
05/03/2012US20120107846 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
05/03/2012US20120107404 Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
05/03/2012US20120107380 Methods of saponifying xanthophyll esters and isolating xanthophylls
05/03/2012US20120107376 Method for improving bioavailability of latanoprost
05/03/2012US20120107328 Gamma secretase modulators
05/03/2012US20120107315 Predicting progression to advanced age-related macular degeneration using a polygenic score
05/03/2012US20120107230 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide Analogs
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 531